What Happened?
Woburn, MA-based Frequency Therapeutics Appointed Jeff Hrkach as Senior Vice President of Technology Development
About the Company
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the controlled activation of progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. Our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the U.S. alone.
About the Person
Jeff Hrkach is Senior Vice President of Technology Development at Frequency Therapeutics. Previously, Jeff held various senior IT leadership roles in the industry.
Info Source
News
Short Profile